Meeting Minutes of the Blood and Tissue Safety Assurance Group Meeting regarding HTVL testing a vCJD Clinical Incident Panel the suitability of plasma from mainland Europe the Paul Ehrlich Institute vCJD risk analysis and the exclusion of previously transfused donors